Skip to content

Clinical trials

Completed Phase 1 Lymphoma, Large B-Cell, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1 Status: Completed Clear all

254 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
20018
200214
20037
200412
20056
20068
200712
20089
20098
20105
20119
20128
201312
20149
20158
20169
201712
201816
201912
20207
20213
20224
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed254

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)48
Memorial Sloan Kettering Cancer Center11
National Institutes of Health Clinical Center (CC)9
Case Comprehensive Cancer Center6
M.D. Anderson Cancer Center6
Mayo Clinic5
Northwestern University5
Regeneron Pharmaceuticals5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Amgen4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse254
Lymphoma, Follicular172
Lymphoma, Mantle-Cell171
Lymphoma, Non-Hodgkin156
Leukemia, Lymphocytic, Chronic, B-Cell145
Burkitt Lymphoma144
Lymphoma, B-Cell, Marginal Zone140
Precursor Cell Lymphoblastic Leukemia-Lymphoma134
Lymphoma, Large-Cell, Immunoblastic121
Lymphoma115

Trials

Showing 1 to 25 of 254. Each trial links to its page on Pharma Observatory.

154 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.